Fantom Bioresorbable Scaffold: Verse, But Not Yet Chorus (An Incomplete Composition). - Suppr | 超能文献

Fantom Bioresorbable Scaffold: Verse, But Not Yet Chorus (An Incomplete Composition).

作者信息

Ellis Stephen G

机构信息

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

出版信息

JACC Cardiovasc Interv. 2017 Sep 25;10(18):1839-1840. doi: 10.1016/j.jcin.2017.06.009.

DOI:10.1016/j.jcin.2017.06.009

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Fantom Bioresorbable Scaffold: Verse, But Not Yet Chorus (An Incomplete Composition).

JACC Cardiovasc Interv. 2017 Sep 25;10(18):1839-1840. doi: 10.1016/j.jcin.2017.06.009.

2

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.生物可吸收依维莫司洗脱支架与金属依维莫司洗脱支架治疗初发原生冠状动脉病变所致缺血性心脏病的比较（ABSORB II）：一项随机对照临床试验的临床和操作次要终点 1 年中期分析。

Lancet. 2015 Jan 3;385(9962):43-54. doi: 10.1016/S0140-6736(14)61455-0. Epub 2014 Sep 14.

3

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.冠状动脉血运重建患者中应用超薄可生物吸收聚合物西罗莫司洗脱支架与薄型持久聚合物依维莫司洗脱支架（BIOFLOW V）：一项随机试验

Lancet. 2017 Oct 21;390(10105):1843-1852. doi: 10.1016/S0140-6736(17)32249-3. Epub 2017 Aug 26.

4

Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.依维莫司洗脱冠状动脉支架与依维莫司洗脱生物可吸收血管支架的比较。

J Am Coll Cardiol. 2015 Mar 3;65(8):791-801. doi: 10.1016/j.jacc.2014.12.017.

5

Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).生物可吸收血管支架与依维莫司洗脱金属支架治疗 ST 段抬高型心肌梗死：倾向评分匹配比较的 1 年结果：BVS-EXAMINATION 研究（生物可吸收血管支架——依维莫司洗脱冠状动脉支架治疗 ST 段抬高型心肌梗死患者的临床评估）。

JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):189-197. doi: 10.1016/j.jcin.2014.10.005.

6

Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.第二代生物可吸收依维莫司药物洗脱血管支架治疗冠状动脉原发狭窄的临床和影像学 6 个月随访结果。

Circulation. 2010 Nov 30;122(22):2301-12. doi: 10.1161/CIRCULATIONAHA.110.970772. Epub 2010 Nov 15.

7

6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold: The FANTOM II Study.新型放射显影西罗莫司洗脱生物可吸收血管支架 6 个月的临床和血管造影结果：FANTOM II 研究。

JACC Cardiovasc Interv. 2017 Sep 25;10(18):1832-1838. doi: 10.1016/j.jcin.2017.07.033.

8

Bioresorbable Drug-Eluting Stents: No Pain, No Gain.

JACC Cardiovasc Interv. 2016 Jun 27;9(12):1228-1230. doi: 10.1016/j.jcin.2016.05.021. Epub 2016 Jun 20.

9

Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trial.依维莫司洗脱冠状动脉支架和生物雷帕霉素洗脱冠状动脉支架与依维莫司洗脱生物可吸收血管支架的比较：EVERBIO II试验的两年临床结果。

Int J Cardiol. 2017 Sep 15;243:121-125. doi: 10.1016/j.ijcard.2017.05.053. Epub 2017 May 12.

10

Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents.依维莫司洗脱生物可吸收支架与依维莫司洗脱金属支架的比较

Ann Intern Med. 2016 Dec 6;165(11):829. doi: 10.7326/L16-0419.

引用本文的文献

1

Bioresorbable Vascular Scaffolds-Dead End or Still a Rough Diamond?生物可吸收血管支架——死胡同还是仍为璞玉？

J Clin Med. 2019 Dec 7;8(12):2167. doi: 10.3390/jcm8122167.

2

Bioresorbable scaffold -fourth revolution or failed revolution: Is low scaffold strut thickness the wrong target?生物可吸收支架——第四次革命还是失败的革命：低支架支柱厚度是错误的目标吗？

Indian Heart J. 2017 Nov-Dec;69(6):687-689. doi: 10.1016/j.ihj.2017.10.004. Epub 2017 Oct 6.